Treatment of Relapsed/Refractory Myeloma (excluding T-cell redirection therapy)
CLINICAL EFFICACY OF ISATUXIMAB PLUS CARFILZOMIB -DEXAMETHASONE IN RELAPSED/REFRACTORY MULTIPLE MYELOMA PATIENTS: AN ITALIAN REAL-LIFE MULTI-CENTER RETROSPECTIVE EXPERIENCE
DANILO DE NOVELLIS, danilo.denovellis
PhD/MD
Hematology and Transplant Center, University Hospital "San Giovanni di Dio e Ruggi d'Aragona", Salerno, Italy